KCNN1

KCNN1 encodes the SK1 subunit of small-conductance calcium-activated potassium (SK) channels, which mediate the afterhyperpolarization (AHP) current that restrains neuronal and cardiomyocyte excitability. Expressed in HEK293 and COS-7 cells, hSK1 forms apamin-sensitive channels blocked by tubocurarine, dequalinium, and UCL1848, and preferentially co-assembles with IKCa (SK4) subunits through COOH-terminal coiled-coil interactions to generate heteromeric channels with reduced Ca²⁺ gating sensitivity (PMID:10683185, PMID:38018635). In dorsal root ganglion neurons, KCNN1 transcription is maintained by the lncRNA SS-lncRNA (which recruits hnRNPM to the Kcnn1 promoter) and by the transcription factor ESRRG; nerve injury downregulates both regulators, silencing KCNN1, diminishing AHP currents, and increasing nociceptive excitability (PMID:37012681, PMID:38912580). KCNN1 also contributes to cardiac action potential repolarization—its downregulation underlies osimertinib-induced proarrhythmic cardiotoxicity in iPSC-derived cardiomyocytes—and in non-excitable contexts it interacts with ERLIN2 to stabilize Cyclin B1 via K63-linked ubiquitination, promoting breast cancer cell proliferation (PMID:40653133, PMID:37831636).

1. 2000 High

   Establishing that hSK1 forms a functional apamin-sensitive Ca²⁺-activated K⁺ channel in mammalian cells resolved whether the biophysical and pharmacological properties seen in Xenopus oocytes were representative of the native channel.

   Evidence Whole-cell patch-clamp with multiple pharmacological probes (apamin, tubocurarine, dequalinium, UCL1848) in transfected HEK293 and COS-7 cells

   PMID:10683185

   Open questions at the time

   • Native tissue recordings confirming these pharmacological sensitivities were not provided
   • Subunit stoichiometry of functional channels not determined
2. 2001 Medium

   Mapping the complex alternative splicing of murine Kcnn1 revealed that most predicted isoforms lack Ca²⁺-independent calmodulin binding, raising the question of which isoforms form functional channels in vivo.

   Evidence RT-PCR, genomic sequencing, and calmodulin-binding domain mapping of mouse SK1 transcripts

   PMID:11267657

   Open questions at the time

   • Functional electrophysiological validation of individual splice variants not performed
   • Tissue-specific isoform expression patterns not fully characterized
3. 2021 Medium

   Demonstrating that specific HDACs positively (HDAC2, 3, 6, 7) or negatively (HDAC9) regulate Kcnn1 transcription in atrial myocytes identified an epigenetic layer controlling SK1 expression in the heart.

   Evidence siRNA knockdown of individual HDACs in HL-1 atrial myocytes with qRT-PCR readout of Kcnn1 mRNA

   PMID:34111326

   Open questions at the time

   • Direct HDAC binding to the Kcnn1 promoter not shown (ChIP not performed)
   • Downstream electrophysiological consequences of HDAC-mediated Kcnn1 changes not measured
4. 2023 High

   Identifying that SS-lncRNA recruits hnRNPM to the Kcnn1 promoter to drive transcription in DRG neurons, and that nerve injury disrupts this axis, established a non-coding RNA mechanism linking KCNN1 silencing to neuropathic pain-associated hyperexcitability.

   Evidence ChIP, RNA pulldown, Co-IP, siRNA knockdown, patch-clamp electrophysiology in DRG neurons, and in vivo behavioral rescue

   PMID:37012681

   Open questions at the time

   • Whether SS-lncRNA–hnRNPM regulation of Kcnn1 operates in tissues beyond DRG neurons is unknown
   • Upstream signals triggering SS-lncRNA downregulation after nerve injury not identified
5. 2023 High

   Showing that hSK1 preferentially co-assembles with hIKCa (SK4) through COOH-terminal coiled-coil interactions to form heteromeric channels with reduced Ca²⁺ sensitivity resolved how SK channel subunit composition tunes gating properties.

   Evidence Coiled-coil domain mutagenesis, pharmacological profiling with TRAM-34, patch-clamp electrophysiology in a heterologous co-expression system

   PMID:38018635

   Open questions at the time

   • Existence and physiological relevance of SK1:IKCa heteromers in native tissues not confirmed
   • Structural basis of preferential heteromeric over homomeric assembly not resolved
6. 2023 Medium

   The discovery that KCNN1 interacts with ERLIN2 to stabilize Cyclin B1 through K63-linked ubiquitination in breast cancer cells revealed an unexpected non-canonical role for an ion channel subunit in cell cycle regulation.

   Evidence Co-immunoprecipitation, K63-specific ubiquitination assays, proliferation and invasion assays in breast cancer cell lines

   PMID:37831636

   Open questions at the time

   • Whether this function requires channel activity or is channel-independent is unknown
   • The E3 ligase mediating K63-ubiquitination in this complex is not identified
   • Single-lab finding without independent replication
7. 2024 High

   Identifying ESRRG as a transcription factor that binds the Kcnn1 promoter and whose downregulation after nerve injury contributes to KCNN1 loss provided a second, independent transcriptional mechanism controlling KCNN1 in DRG neurons and neuropathic pain.

   Evidence ChIP assay for ESRRG binding, AAV-mediated KCNN1 rescue, patch-clamp electrophysiology, siRNA knockdown, behavioral nociceptive assays

   PMID:38912580

   Open questions at the time

   • How ESRRG and SS-lncRNA/hnRNPM pathways interact or converge at the Kcnn1 promoter is not addressed
   • Upstream signals causing ESRRG downregulation after nerve injury not identified
8. 2024 Medium

   Demonstrating that EWS::FLI1 fusion oncoproteins directly activate KCNN1 transcription via GGAA microsatellites and that KCNN1 regulates membrane potential, calcium flux, and cell cycle in Ewing sarcoma extended the functional repertoire of SK1 into oncogenic signaling contexts.

   Evidence ChIP-seq for EWS::FLI1 binding at KCNN1 locus, siRNA knockdown, cell cycle analysis, membrane potential and calcium flux measurements

   PMID:39487324

   Open questions at the time

   • Whether KCNN1 channel activity or a channel-independent function mediates the cell cycle effect is unclear
   • In vivo relevance in Ewing sarcoma tumor models not tested
9. 2025 Medium

   Showing that osimertinib-induced KCNN1 downregulation in iPSC-derived cardiomyocytes causes action potential prolongation and early afterdepolarizations, reversible by KCNN1 rescue, established KCNN1 as a mediator of drug-induced proarrhythmic cardiotoxicity.

   Evidence RNA-seq, qRT-PCR, Western blotting, optical mapping of action potential duration in hiPSC-CMs, KCNN1 rescue experiments, zebrafish in vivo model

   PMID:40653133

   Open questions at the time

   • Mechanism by which osimertinib downregulates KCNN1 is not elucidated
   • Clinical relevance of KCNN1 loss in human cardiac arrhythmia patients not established

• Key unresolved questions include the structural basis of SK1 heteromeric assembly preferences, whether KCNN1's non-canonical roles in cell proliferation are channel-dependent or channel-independent, and how the multiple transcriptional regulators (SS-lncRNA/hnRNPM, ESRRG, HDACs, EWS fusions) are integrated at the Kcnn1 promoter in different cell types.
• No high-resolution structure of SK1 homomeric or heteromeric channel exists
• Channel-dependent versus channel-independent functions in non-excitable cells not delineated
• Integrative promoter model unifying multiple transcriptional inputs has not been built